Abiopharma

🔍 McCreight David W. (Director)

Company: CARMAX INC (KMX)

Report Date: 2026-03-16

Detailed Transactions and Holdings:

• Acquired 30,558 shares of Common Stock at $41.71 per share (Direct)
  Date: 2026-03-16 | Code: M | equity_swap_involved: 0 | shares_owned_after: 47,257.00 | transaction_form_type: 4
• Sold 11,423 shares of Common Stock at $41.71 per share (Direct)
  Date: 2026-03-16 | Code: F | equity_swap_involved: 0 | shares_owned_after: 35,834.00 | transaction_form_type: 4
• Sold 30,558 shares of Restricted Stock Units (Derivative)
  Date: 2026-03-16 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of Common Stock.
• F2: On December 26, 2025, the Reporting Person was granted 91,673 RSUs, of which 30,558 vested on March 16, 2026, the date on which he ceased serving as the Company's Interim President and Chief Executive Officer. In accordance with the terms of the applicable award agreement, the remaining 61,085 RSUs were forfeited.